Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
AstraZeneca
Express Scripts
Chubb
Chinese Patent Office
Accenture
Covington
Queensland Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

ISMOTIC Drug Profile

« Back to Dashboard

Which patents cover Ismotic, and when can generic versions of Ismotic launch?

Ismotic is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in ISMOTIC is isosorbide. There are thirty-seven drug master file entries for this compound. Additional details are available on the isosorbide profile page.
Drug patent expirations by year for ISMOTIC
Medical Subject Heading (MeSH) Categories for ISMOTIC
Synonyms for ISMOTIC
(+)-D-Isosorbide
(3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol
(3S,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol
1,4-Dianhydrosorbitol
1,4; 3,6-dianhydrosorbitol
1,4:3,6-Dianhydro-D-glucitol
1,4:3,6-Dianhydro-D-sorbitol
1,4:3,6-Dianhydro-D-sorbitol, D-Isosorbide
1,4:3,6-Dianhydroglucitol
1,4:3,6-Dianhydrosorbitol
1,6-Dianhydro-D-glucitol
1,6-Dianhydro-D-sorbitol
1,6-Dianhydrosorbitol
1.4;3.6-dianhydro-D-glucitol
1.4:3.6-dianhydro-D-glucitol
151380-60-8
152881-21-5
42750-75-4
49871-92-3
5-19-03-00201 (Beilstein Handbook Reference)
50974-60-2
52906-EP2269989A1
52906-EP2270017A1
52906-EP2295406A1
52906-EP2298772A1
52906-EP2301941A1
52906-EP2305219A1
52906-EP2308839A1
52906-EP2308881A1
652-67-5
A912284D-27E1-4FB0-91B8-86C8AB905297
AB01566931_01
AC1L1ZXO
AJ-70553
AK116074
AKOS005622709
AN-20473
AS-14140
AT-101, Atumida
BBL029591
BIDD:GT0695
Bio-0643
BRN 0080510
CA011050
CAS-652-67-5
CHEBI:6060
CHEMBL1200660
CS-5157
D-1,4:3,6-Dianhydroglucitol
D-Glucitol, 1,4:3,6-dianhydro-
D-Glucitol,4:3,6-dianhydro-
D-Isosorbide, 98% 50g
D-Sorbitol, {1,4:3,6-dianhydro(furo[3,2-b]furan-3,6-diol,} hexahydro-)
D-Sorbitol,4:3,6-dianhydro(furo[3,2-b]furan-3,6-diol, hexahydro-)
D00347
D0S6KI
Devicoran
Dianhydro-D-glucitol
Dianhydro-D-glucitol, 98%
Dianhydrosorbitol
DSSTox_CID_26196
DSSTox_GSID_46196
DSSTox_RID_81427
DTXSID5046196
EINECS 211-492-3
FT-0606757
Glucitol, 1,4:3,6-dianhydro-, D-
Glucitol,4:3,6-dianhydro-, D-
HE009203
HSDB 3105
HY-B1469
Hydronol
Hydronol (VAN)
Hyperpermeability inhibitor (hemorrhagic shock), Atumida
I0407
I14-17633
Ismotic (TN)
Isobide
Isobide (TN)
Isosorbida
Isosorbida [INN-Spanish]
isosorbide
Isosorbide (JP17/USP/INN)
Isosorbide [USAN:INN:BAN:JAN]
Isosorbidum
Isosorbidum [INN-Latin]
K060
KB-207523
KLDXJTOLSGUMSJ-JGWLITMVSA-N
LS-71370
MCULE-2567091829
MFCD00064827
MolPort-000-812-960
NCGC00160508-01
NCGC00160508-02
NCGC00160508-03
NSC 40725
NSC-40725
NSC40725
s4204
SCHEMBL15495
SMP1_000177
Sorbid
Sorbitol, 1,4:3,6-dianhydro-
ST24026231
STK801813
TL8004635
Tox21_111861
Tox21_111861_1
UNII-WXR179L51S
Vascardin dinitrate
WXR179L51S
Z-3120
Z2785909604
ZINC18284778

US Patents and Regulatory Information for ISMOTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon ISMOTIC isosorbide SOLUTION;ORAL 017063-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
QuintilesIMS
McKinsey
Johnson and Johnson
Cantor Fitzgerald
Citi
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.